arcadia

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE420.00-5.8 (-1.36 %)
PREV CLOSE ( ) 425.80
OPEN PRICE ( ) 426.00
BID PRICE (QTY) 420.00 (198)
OFFER PRICE (QTY) 420.20 (693)
VOLUME 374717
TODAY'S LOW / HIGH ( )417.45 427.00
52 WK LOW / HIGH ( )350.4 678.8
NSE419.30-6.7 (-1.57 %)
PREV CLOSE( ) 426.00
OPEN PRICE ( ) 426.00
BID PRICE (QTY) 419.30 (14)
OFFER PRICE (QTY) 419.50 (688)
VOLUME 4435595
TODAY'S LOW / HIGH( ) 417.30 426.50
52 WK LOW / HIGH ( )344.55 679.3
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Israel Makov - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
17Aug Sun Pharma, CMS ink licensing agreemen
Sun Pharmaceutical Industries’ one of wholly owned subsidiaries has gran..
14Aug CONCOR, Infosys and Wipro to see some
Container Corporation of India (CONCOR) and Indian Railways have joined..
14Aug Sun Pharma enters into licensing agree
Sun Pharmaceutical Industries has entered into a global licensing agreem..
13Aug Sun Pharma reports 31% rise in Q1 cons
Sun Pharmaceutical Industries has reported results for first quarter end..
03Aug Sun Pharma discontinues operations at
Sun Pharmaceutical Industries is discontinuing operations at two clinica..
Financials
Rs. in Millions
QTR Jun 19 ANNUAL 19
Net Profit7633.78166
Gross Profit 7681.4 7194.5
Operating Profit 9609.730277
Net Sales 33090.1103032.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddys Lab (BSE)
 2549.85 (1.57%)
M.Cap ( in Cr)42354.88
Jenburkt Pharma (BSE)
 455.00 (7.06%)
M.Cap ( in Cr)208.82
Astrazeneca Pharma I (BSE)
 1761.00 (1.65%)
M.Cap ( in Cr)4395.00
Alkem Laboratories (BSE)
 1770.40 (1.35%)
M.Cap ( in Cr)21062.57
Everest Organics (BSE)
 181.00 (13.13%)
M.Cap ( in Cr)144.80
Shareholding Pattern
PROMOTERS 54.38%
NON-INSTITUTION 12.71%
MUTUAL FUNDS/UTI 10.26%
FI/BANKS/INSURANCE 7.67%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM